Controls | IgAN total | IgAN without progression | IgAN with progression | |
---|---|---|---|---|
N | 15 | 25 | 16 | 9 |
Year of diagnosis | 2000 ± 7.7 | 1997 ± 4.4 | 1996 ± 3.4 | 1998 ± 5.7 |
Proportion female | 53.3% | 20% | 12.5% | 33.3% |
Age (years) | 32.0 ± 11.9 | 31.3 ± 14 | 31.4 ± 13.4 | 31.2 ± 15.8 |
Serum creatinine (mmol/l) | 79.3 ± 20.9 | 96.6 ± 23.6 * | 91.5 ± 21.5 | 105.8 ± 25.6* |
Estimated glomerular filtration rate ª (ml/min/1.73m2) | 113.13 ± 18.5 | 106.16 ± 27.43 | 114.19 ± 25.3 | 91.89 ± 26.3* |
Systolic blood pressure (mmHg) | 118.6 ± 14.6 | 130.2 ± 19.2 | 127.2 ± 14.3 | 135.4 ± 25.8 |
Diastolic blood pressure (mmHg) | 77.6 ± 8.4 | 78.8 ± 11.9 | 78.9 ± 11.6 | 78.8 ± 13.1 |
Urinary protein (grams/24 h) | 0.16 ± 0.17 | 1.7 ± 1.03 * | 1.76 ± 1 * | 2.0 ± 2.0 * |
Body weight (kg) | 74.7 ± 11.9 | 75.8 ± 9.9 | 76.1 ± 8.0 | 75.4 ± 12.5 |
No of years of follow-up | 12.3 ± 7.7 | 16.3 ± 3.4 | ||
No of years from biopsy to ESRD | 5.8 ± 2.5 | |||
Percentage with M-score of 1b | Not applicable | 36% | 31.3% | 44.4% |
Percentage with E-score of 1b | Not applicable | 32% | 31.3% | 33.3% |
Percentage with S-score of 1b | Not applicable | 60% | 50% | 77.8% |
Percentage with T-score of 1 or 2b | Not applicable | 16% | 0% | 44.4% ** |
Percentage with C-score of 1b | Not applicable | 4% | 0% | 11.1% |